A Feasibility Study of Oral Adjuvant Chemotherapy With S-1
NCT01459185
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
DRUG:
S-1
Sponsor
Tomoshi Tsuchiya